TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
MGX

Metagenomi, Inc.

Healthcare · Biotechnology

1.10$ +1.8% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow MGX
Line item 2021 2022 2023 2024 2025
+22.5% -407.5%
+347.8% +142.8% +28.5% -1.7%
+423.2% +252.8% +134.1% -26.9%
+50.2% -138.0%
+381.5% -29.8% -68.3% -81.6%
+64.4% -292.8%
-100.0%
+500.2% -99.6% +8,201.7% -100.4%
-130.4%
-26.3% -742.8%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?